Monitoring anti-PD-1-based immunotherapy in non-small cell lung cancer with FDG PET: introduction of iPERCIST

by Lucas Goldfarb, Boris Duchemann, Kader Chouahnia, Laurent Zelek, Michael Soussan
Published 2019-01-01

18F-FDG PET-Derived Textural Indices Reflect Tissue-Specific Uptake Pattern in Non-Small Cell Lung Cancer.

by Fanny Orlhac, Michaël Soussan, Kader Chouahnia, Emmanuel Martinod, Irène Buvat
Published 2015-01-01

First-line immune-checkpoint inhibitor plus chemotherapy chemotherapy alone for extensive-stage small-cell lung cancer: a meta-analysis

by Thierry Landre, Kader Chouahnia, Gaëtan Des Guetz, Boris Duchemann, Jean-Baptiste Assié, Christos Chouaïd
Published 2020-12-01

Impact of Physical Activity on Cancer-Specific and Overall Survival of Patients with Colorectal Cancer

by Gaetan Des Guetz, Bernard Uzzan, Thierry Bouillet, Patrick Nicolas, Kader Chouahnia, Laurent Zelek, Jean-François Morere
Published 2013-01-01

Budget Impact Analysis of Fixed Dose Versus Weight-Based Dosing Regimen of Nivolumab and Pembrolizumab in the Treatment of Non-Small Cell Lung Cancer

by Sanjana Monirul, Marthe Rigal, Kader Chouahnia, Mélisande Le Jouan, Maxime Apparuit, Adrien Paix, Anne Jacolot, Laurent Zelek, Boris Duchemann
Published 2020-12-01